![Cigall Kadoch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cigall Kadoch
Direktor/Vorstandsmitglied bei
Massachusetts Institute of Technology
Vermögen: 16 Mio $ am 31.05.2026
Profil
Cigall Kadoch was the founder of Foghorn Therapeutics, Inc. and held the title of Director from 2015 to 2022.
Current jobs include Director at Harvard University since 2014, Director at Massachusetts Institute of Technology since 2014, Associate Professor at Dana-Farber Cancer Institute, Inc. since 2014, Advisor at GV Management Co. LLC, and Assistant Professor at Harvard Medical School.
Education history includes an undergraduate degree from the University of California, Berkeley conferred in 2007 and a doctorate from Stanford University School of Medicine conferred in 2012.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.04.2026 | 3’624’379 ( 6.17% ) | 16 Mio $ | 31.05.2026 |
Aktive Positionen von Cigall Kadoch
| Unternehmen | Position | Beginn |
|---|---|---|
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Direktor/Vorstandsmitglied | 01.04.2014 |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | 01.04.2014 |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Corporate Officer/Principal | 01.01.2014 |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
GV Management Co. LLC
 GV Management Co. LLC Investment ManagersFinance Google Ventures invests in companies located in North America, Europe and Israel. The firm focuses on companies operating in the fields of technology and life sciences sectors. It provides financing for seed, early and growth stage capital requirements. | Berater | - |
Ehemalige bekannte Positionen von Cigall Kadoch
| Unternehmen | Position | Ende |
|---|---|---|
| FOGHORN THERAPEUTICS INC. | Gründer | 31.08.2022 |
Ausbildung von Cigall Kadoch
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
93
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Health Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GV Management Co. LLC
GV Management Co. LLC Investment ManagersFinance Google Ventures invests in companies located in North America, Europe and Israel. The firm focuses on companies operating in the fields of technology and life sciences sectors. It provides financing for seed, early and growth stage capital requirements. | Finance |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Foghorn Therapeutics, Inc.
 Foghorn Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops novel drugs to treat cancer and other serious medical disorders | Health Technology |
